Start-Up Previews, June 2013
This Month's Profile Group: Medtech Start-Ups Aim To Reverse The Downward Spiral of Heart Failure, features profiles of BioVentrix, Calon Cardio-Technology, Cibiem, DC Devices, and LoneStar Heart. Plus these Start-Ups Across Health Care: Dialog Devices, Lumena Pharmaceuticals, and STAT-Diagnostica.
You may also be interested in...
Rapid diagnosis of infectious diseases can make the difference between life and death in hospitals, but the wait for results from standard hospital in-house laboratory tests may take days. STAT-Diagnostica & Innovation SL’s self-contained mini-lab is not only portable and can be administered easily by a nurse, but it also allows for a short, 30-minute turnaround time from taking a patient specimen to identifying one of roughly 50 specific pathogens associated mainly with infectious diseases.
The Vascular Early Warning System from UK-based Dialog Devices Ltd. is a portable, handheld device to scan patients for peripheral arterial disease quickly in a primary care physician’s office. The automated functional test can be performed in about 10 minutes and improves upon the ankle brachial pressure index, which is the current first-line examination for suspected PAD.
LoneStar Heart's injectable biopolymer Algisyl-LVR represents a new advanced HF treatment strategy based on a medically accepted principle that a reduction in muscle tension and wall stress of the dilated heart will improve its function. The company, which originally envisioned Algisyl-LVR as a carrier for targeted delivery of biologics, drugs, or stem cells, discovered in animal studies that use of the biopolymer by itself had a profound effect on improving the mechanics of the heart.